NEU 0.07% $13.76 neuren pharmaceuticals limited

An aquirer will likely have many other parts. So the exposure...

  1. 5,801 Posts.
    lightbulb Created with Sketch. 334


    An aquirer will likely have many other parts. So the exposure for Neurens assets would be highly diluted if a current shareholder invested in the aquirer.

    Thus it would`t be effective. IMO

    Best to get the maximum possible when/if TO occurs. Not good enough offer, send `em packing.

    It will really depend if there is more than 1 suitor.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.76
Change
0.010(0.07%)
Mkt cap ! $1.753B
Open High Low Value Volume
$13.85 $14.08 $13.46 $4.693M 342.8K

Buyers (Bids)

No. Vol. Price($)
15 863 $13.75
 

Sellers (Offers)

Price($) Vol. No.
$13.76 43 6
View Market Depth
Last trade - 15.24pm 10/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.